The only information in the literature associating this protein with breast cancer described a decrease of SGSM3 mRNA in breast cancer tissue compared to normal tissue [98], which is in contrast with the significant increase of expression in LCLs of BRCAX affected individuals observed in our study. The gene discussed is SGSM3; the disease is breast carcinoma.